Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Jan;32(1):46–50. doi: 10.1128/jcm.32.1.46-50.1994

Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results.

A D Pronovost 1, S L Rose 1, J W Pawlak 1, H Robin 1, R Schneider 1
PMCID: PMC262967  PMID: 8126203

Abstract

Infection with Helicobacter pylori has been associated with the pathogenesis of chronic active gastritis and gastric and duodenal ulcer disease. Detection of immunoglobulin G antibodies to H. pylori offers a simple alternative to direct detection of the organism in biopsied tissue by culture or histopathological methods. A rapid flow-through membrane-based enzyme immunoassay for the detection of human immunoglobulin G antibodies to H. pylori has been developed and evaluated. Clinical evaluations were performed with 256 patient serum samples obtained from four clinical sites. Biopsy samples were obtained by endoscopic procedures at the same time as the serum samples, and were histopathologically and microbiologically categorized for the presence or absence of H. pylori. Sensitivity and specificity for this rapid enzyme immunoassay were 92 and 88%, respectively, compared directly with endoscopy results. After discordant results were resolved by a quantitative microwell enzyme-linked immunosorbent assay, the resulting sensitivity and specificity were 94 and > 99%, respectively. These results indicate that this rapid enzyme immunoassay is a useful technique to determine H. pylori infection status and is a viable alternative to invasive endoscopic procedures.

Full text

PDF
46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansorg R., Von Recklinghausen G., Pomarius R., Schmid E. N. Evaluation of techniques for isolation, subcultivation, and preservation of Helicobacter pylori. J Clin Microbiol. 1991 Jan;29(1):51–53. doi: 10.1128/jcm.29.1.51-53.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Befrits R., Granström M., Rylander M., Rubio C. Helicobacter pylori in 205 consecutive endoscopy patients. Scand J Infect Dis. 1993;25(2):185–191. doi: 10.3109/00365549309008483. [DOI] [PubMed] [Google Scholar]
  3. Brown K. E., Peura D. A. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am. 1993 Mar;22(1):105–115. [PubMed] [Google Scholar]
  4. Dooley C. P., Cohen H., Fitzgibbons P. L., Bauer M., Appleman M. D., Perez-Perez G. I., Blaser M. J. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989 Dec 7;321(23):1562–1566. doi: 10.1056/NEJM198912073212302. [DOI] [PubMed] [Google Scholar]
  5. Drumm B., Perez-Perez G. I., Blaser M. J., Sherman P. M. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med. 1990 Feb 8;322(6):359–363. doi: 10.1056/NEJM199002083220603. [DOI] [PubMed] [Google Scholar]
  6. Goodwin C. S., Blincow E., Peterson G., Sanderson C., Cheng W., Marshall B., Warren J. R., McCulloch R. Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis. 1987 Mar;155(3):488–494. doi: 10.1093/infdis/155.3.488. [DOI] [PubMed] [Google Scholar]
  7. Graham D. Y., Lew G. M., Malaty H. M., Evans D. G., Evans D. J., Jr, Klein P. D., Alpert L. C., Genta R. M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb;102(2):493–496. doi: 10.1016/0016-5085(92)90095-g. [DOI] [PubMed] [Google Scholar]
  8. Hirschl A. M., Brandstätter G., Dragosics B., Hentschel E., Kundi M., Rotter M. L., Schütze K., Taufer M. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis. 1993 Sep;168(3):763–766. doi: 10.1093/infdis/168.3.763. [DOI] [PubMed] [Google Scholar]
  9. Hoek F. J., Noach L. A., Rauws E. A., Tytgat G. N. Evaluation of the performance of commercial test kits for detection of Helicobacter pylori antibodies in serum. J Clin Microbiol. 1992 Jun;30(6):1525–1528. doi: 10.1128/jcm.30.6.1525-1528.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones D. M., Eldridge J., Fox A. J., Sethi P., Whorwell P. J. Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol. 1986 Aug;22(1):57–62. doi: 10.1099/00222615-22-1-57. [DOI] [PubMed] [Google Scholar]
  11. Kosunen T. U., Seppälä K., Sarna S., Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 1992 Apr 11;339(8798):893–895. doi: 10.1016/0140-6736(92)90929-w. [DOI] [PubMed] [Google Scholar]
  12. Lin S. K., Lambert J. R., Schembri M., Nicholson L., Finlay M., Wong C., Coulepis A. A comparison of diagnostic tests to determine Helicobacter pylori infection. J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):203–209. doi: 10.1111/j.1440-1746.1992.tb00963.x. [DOI] [PubMed] [Google Scholar]
  13. Logan R. P., Gummett P. A., Misiewicz J. J., Karim Q. N., Walker M. M., Baron J. H. Two-week eradication regimen for metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther. 1993 Apr;7(2):149–153. doi: 10.1111/j.1365-2036.1993.tb00083.x. [DOI] [PubMed] [Google Scholar]
  14. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  15. Morgan D. R., Freedman R., Depew C. E., Kraft W. G. Growth of Campylobacter pylori in liquid media. J Clin Microbiol. 1987 Nov;25(11):2123–2125. doi: 10.1128/jcm.25.11.2123-2125.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morris A., Nicholson G., Lloyd G., Haines D., Rogers A., Taylor D. Seroepidemiology of Campylobacter pyloridis. N Z Med J. 1986 Sep 10;99(809):657–659. [PubMed] [Google Scholar]
  17. Mégraud F., Brassens-Rabbé M. P., Denis F., Belbouri A., Hoa D. Q. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol. 1989 Aug;27(8):1870–1873. doi: 10.1128/jcm.27.8.1870-1873.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ng T. M., Fock K. M., Ho J., Tan A. L., Chia S. C., Yap C. K., Chew C. N., Chee E. N. Clotest (rapid urease test) in the diagnosis of Helicobacter pylori infection. Singapore Med J. 1992 Dec;33(6):568–569. [PubMed] [Google Scholar]
  19. Perez-Perez G. I., Dworkin B. M., Chodos J. E., Blaser M. J. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988 Jul 1;109(1):11–17. doi: 10.7326/0003-4819-109-1-11. [DOI] [PubMed] [Google Scholar]
  20. Rugge M., Di Mario F., Cassaro M., Baffa R., Farinati F., Rubio J., Jr, Ninfo V. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology. 1993 Jan;22(1):9–15. doi: 10.1111/j.1365-2559.1993.tb00062.x. [DOI] [PubMed] [Google Scholar]
  21. Talley N. J., Kost L., Haddad A., Zinsmeister A. R. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec;30(12):3146–3150. doi: 10.1128/jcm.30.12.3146-3150.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES